ArticleBreast cancer research and treatment2024

Assessment of efficacy and safety of dose-dense doxorubicin and cyclophosphamide (ddAC) in combination with immunotherapy in early-stage triple-negative breast cancer.

Olivia White et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.